Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

Delayed Data
As of Sep 22
 +1.61 / +2.09%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 97.00, with a high estimate of 125.00 and a low estimate of 52.00. The median estimate represents a +23.47% increase from the last price of 78.56.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 68.92%
Growthannually 20.63%


Growthquarterly 42.39%
Growthannually 93,707.82%
Key to the earnings and sales forecast charts.